Explore over 200 documented G6PD variants with clinical classifications, enzyme activity levels, and geographic distributions.
The most clinically significant G6PD variants worldwide
| Variant Name | Mutation | Class | Activity | Prevalence |
|---|---|---|---|---|
| G6PD Mediterranean | S188F | Class II | 0-10% | Mediterranean, Middle East |
| G6PD A- | V68M + N126D | Class III | 8-20% | Sub-Saharan Africa |
| G6PD Canton | R459L | Class II | 4-25% | Southeast Asia, China |
| G6PD Mahidol | G163S | Class III | 5-32% | Thailand, Myanmar |
| G6PD Seattle | D282H | Class IV | 60-100% | Sardinia, Papua New Guinea |
| G6PD Orissa | A44G | Class III | 10-25% | India |
| G6PD Vanua Lava | L128P | Class II | 1-7% | Vanuatu, Pacific Islands |
| G6PD Aurès | I48T | Class II | 5-10% | North Africa |
Residual enzyme activity levels across different variant classes
G6PD deficiency prevalence correlates with historical malaria-endemic regions